R Sanders Williams - Net Worth and Insider Trading
R Sanders Williams Net Worth
The estimated net worth of R Sanders Williams is at least $3 Million dollars as of 2024-04-28. R Sanders Williams is the Director of Amgen Inc and owns about 5,301 shares of Amgen Inc (AMGN) stock worth over $1 Million. R Sanders Williams is the Director of Laboratory Corp of America Holdings and owns about 6,431 shares of Laboratory Corp of America Holdings (LH) stock worth over $1 Million. R Sanders Williams is also the Director of Bristol-Myers Squibb Co and owns about 500 shares of Bristol-Myers Squibb Co (BMY) stock worth over $22,425. Details can be seen in R Sanders Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R Sanders Williams has not made any transactions after 2022-08-22 and currently still holds the listed stock(s).
Transaction Summary of R Sanders Williams
R Sanders Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Sanders Williams owns 4 companies in total, including Amgen Inc (AMGN) , Laboratory Corp of America Holdings (LH) , and Bristol-Myers Squibb Co (BMY) among others .
Click here to see the complete history of R Sanders Williams’s form 4 insider trades.
Insider Ownership Summary of R Sanders Williams
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AMGN | Amgen Inc | 2022-08-22 | director |
LH | Laboratory Corp of America Holdings | 2022-03-25 | director |
BMY | Bristol-Myers Squibb Co | 2006-09-11 | director |
TNYA | Tenaya Therapeutics Inc | 2021-07-29 | director |
R Sanders Williams Latest Holdings Summary
R Sanders Williams currently owns a total of 3 stocks. Among these stocks, R Sanders Williams owns 5,301 shares of Amgen Inc (AMGN) as of August 22, 2022, with a value of $1 Million and a weighting of 52.43%. R Sanders Williams owns 6,431 shares of Laboratory Corp of America Holdings (LH) as of March 25, 2022, with a value of $1 Million and a weighting of 46.75%. R Sanders Williams also owns 500 shares of Bristol-Myers Squibb Co (BMY) as of September 11, 2006, with a value of $22,425 and a weighting of 0.82%.
Latest Holdings of R Sanders Williams
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMGN | Amgen Inc | 2022-08-22 | 5,301 | 269.98 | 1,431,164 |
LH | Laboratory Corp of America Holdings | 2022-03-25 | 6,431 | 198.40 | 1,275,910 |
BMY | Bristol-Myers Squibb Co | 2006-09-11 | 500 | 44.85 | 22,425 |
Holding Weightings of R Sanders Williams
R Sanders Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, R Sanders Williams has made a total of 10 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Amgen Inc is the sale of 200 shares on August 22, 2022, which brought R Sanders Williams around $49,992.
According to the SEC Form 4 filings, R Sanders Williams has made a total of 5 transactions in Laboratory Corp of America Holdings (LH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Laboratory Corp of America Holdings is the sale of 572 shares on March 25, 2022, which brought R Sanders Williams around $156,145.
According to the SEC Form 4 filings, R Sanders Williams has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 0 shares on September 11, 2006, which brought R Sanders Williams around $0.
Insider Trading History of R Sanders Williams
- 1
R Sanders Williams Trading Performance
R Sanders Williams Ownership Network
Ownership Network List of R Sanders Williams
Ownership Network Relation of R Sanders Williams
R Sanders Williams Owned Company Details
What does Amgen Inc do?
Who are the key executives at Amgen Inc?
R Sanders Williams is the director of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .
Amgen Inc (AMGN) Insider Trades Summary
Over the past 18 months, R Sanders Williams made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 2,641 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,586 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,586 shares.
Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amgen Inc Insider Transactions
R Sanders Williams Mailing Address
Above is the net worth, insider trading, and ownership report for R Sanders Williams. You might contact R Sanders Williams via mailing address: Duke University School Of Medicine, Trent Drive, Durham Nc 27706.